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Abstract: A key step during the biosynthesis of cytochala-
sans is a proposed Knoevenagel condensation to form the
pyrrolone core, enabling the subsequent 4 + 2 cycloaddition
reaction that results in the characteristic octahydroisoindol-
one motif of all cytochalasans. In this work, we investigate
the role of the highly conserved a,b-hydrolase enzymes PyiE
and ORFZ during the biosynthesis of pyrichalasin H and the
ACE1 metabolite, respectively, using gene knockout and
complementation techniques. Using synthetic aldehyde
models we demonstrate that the Knoevenagel condensation
proceeds spontaneously but results in the 1,3-dihydro-2H-
pyrrol-2-one tautomer, rather than the required 1,5-dihydro-
2H-pyrrol-2-one tautomer. Taken together our results sug-
gest that the a,b-hydrolase enzymes are essential for first
ring cyclisation, but the precise nature of the intermediates
remains to be determined.
Introduction
Cytochalasans are secondary metabolites that have been iso-
lated from a wide range of fungi and that possess numerous
potent bioactivities extensively reviewed elsewhere.[1, 2] As
might be expected for metabolites that have been known
since the mid-1960s,[3] their biosynthesis has been extensively
studied,[4, 5] and their intriguing structures have been the target
for numerous total synthesis campaigns.[6]
We have investigated the biosynthesis of pyrichalasin H 1
from the fungus Magnaporthe grisea (Scheme 1).[7] The results
to-date are consistent with an overall pathway in which O-
methyl tyrosine 2 is created by PyiA and used as the initial
building-block by the polyketide synthase non-ribosomal pep-
tide synthetase (PKS-NRPS) PyiS which acts in concert with the
trans-enoyl reductase (ER) PyiC. PyiS has a reductive release
system and it is hypothesised that an aldehyde intermediate
Scheme 1. Comparison of the pyi and ACE1 BGC and proposed biosynthesis
of metabolites encoded by these BGC.
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such as 3 is released. Cyclisation of 3 by a Knoevenagel process
is then proposed to give 4,[8] and Diels–Alder (DA) reaction
could then give the observed cytochalasan skeleton of 5. The
function of tailoring enzymes PyiBDGH has been proven using
gene knockout (KO) and heterologous expression experiments
during the formation of the mature metabolite 1.[9] Meanwhile,
pyiR encodes a transcription-factor which we have shown to
be responsible for increasing the titre of 1.[10] Recently we
showed that PyiF is involved in the proposed DA reaction.[11,12]
These observations leave PyiE, which encodes a putative hy-
drolytic enzyme, to be proposed as the Knoevenagel catalyst
by default since all other proteins encoded by the pyrichalasin
biosynthetic gene cluster (pyi BGC) have proven roles. In addi-
tion, compounds 3 and 4 (or their analogues in other path-
ways) have never been directly observed, so uncertainty re-
mains regarding the early biosynthetic steps.
We have also investigated the parallel ACE1 biosynthetic
pathway[13] in the closely related fungus Pyricularia oryzae
(Scheme 1). P. oryzae causes rice blast disease and the ACE1
metabolite is involved in avirulence signalling between the
fungal pathogen and resistant rice plants. The ACE1 BGC is
only active in single cell appressoria for a matter of hours
during initial fungal penetration of plant leaves, so the identity
of the ACE1 metabolite is not known. It has also been impossi-
ble, for the same reasons, to perform productive KO experi-
ments in the ACE1 system.[14] However, the high gene-for-gene
homologies between the ACE1 and pyi genes, and the fact that
ACE1 genes can complement knockouts in the pyi BGC mean
that the ACE1 metabolite is very likely to be a cytochalasan de-
rived from 2. Heterologous expression experiments[15] have
also reinforced this hypothesis. Expression of ACE1 (PKS-NRPS)
and RAP1 (trans-ER) in Aspergillus oryzae lead to the production
of various shunt compounds such as 6 a and 6 b in the ab-
sence of 2,[15] and 6 c when 2 is supplied. It is assumed that
these are derived by rapid reduction of putative aldehyde in-
termediates such as 7.[16] Interestingly, putative intermediate 7
differs from the proposed pyrichalasin aldehyde intermediate 3
by being two carbons longer showing that the ACE1 PKS is dif-
ferently programmed.
Hydrolytic enzymes similar to PyiE, and its ACE1 homolog
ORFZ, are encoded in the BGC of all known cytochalasans,[17]
as well as in other BGC which encode the biosynthesis of com-
pounds such as fusarin C where the PKS-NRPS has a reductive
release mechanism.[18] However, the precise function of these
hydrolytic enzymes remains unknown. As part of ongoing
studies into the biosynthesis of cytochalasans we therefore de-
cided to investigate PyiE from M. grisea and ORFZ from
P. oryzae in more detail.
Results
Knockout of pyiE
Disruption of pyiE in M. grisea was achieved by insertion of a
hygromycin resistance cassette using the bipartite method of
Neilsen and co-workers.[19] Examination of organic extracts
from M. grisea DpyiE showed that, in comparison to extracts
from wild-type (WT) M. grisea, production of 1 was significantly
reduced, concomitantly with an increase in production of
known pyriculols.[20] We then re-introduced a copy of either
pyiE itself or its homolog ORFZ, under the control of the Asper-
gillus oryzae amyB promoter (PamyB), into the KO strain using
previously reported methods.[21] In previous work we had
shown that PamyB is functional in M. grisea and we therefore ex-
pected that biosynthesis of 1 should be restored to WT
titres.[7, 11] However, LCMS analysis showed that 1 was not pro-
duced in significantly increased titre for either complementa-
tion experiment (Figure 1 and Figures S6.1–S6.6).
The LCMS profiles obtained from these strains were similar
to those we had observed during KO of pyiA.[7] Since the target
gene pyiE is adjacent to pyiA (Scheme 1) we considered it pos-
sible that either pyiA itself, or the putative bidirectional pro-
moter region between pyiE and pyiA, may have been damaged
by the pyiE engineering. We tested this possibility by feeding
O-methyl tyrosine 2 to cultures of M. griseaDpyiE, M. griseaD
pyiE:PamyB·pyiE and M. griseaDpyiE:PamyB·ORFZ. In the case of the
M. griseaDpyiE:PamyB·pyiE and M. griseaDpyiE:PamyB·ORFZ strains
production of 1 was substantially restored (Figure 1 and Fig-
ures S6.1 to S6.6).
In the DpyiE + 2 experiments a major new peak eluting at
5.1 minutes was also observed (Figure 2). Mass data corre-
sponded to the pre-Diels–Alder intermediates or shunt metab-
olites. Mass spectrometric analysis indicated a mass of 519 Da,
also consistent with compounds related to 1 (e.g. 10, m/z 521).
This compound was detected in both WT and the DpyiE
mutant, but in much lower amounts (Figure S6.9). The major
isomer eluting at 5.1 min was purified by mass-directed prepa-
rative reverse-phase chromatography. HRMS indicated a formu-
la of C29H45NO7 (observed 542.3096, calculated 542.3094 for
C29H45NNaO7) consistent with the 29 main-chain carbons of 1.
Full NMR analysis (Supporting Information, section S7) showed
the compound to be 9, confirming it as a pre-cyclisation shunt
compound. Reduction of the expected C-21 aldehyde to a pri-
mary alcohol is consistent with the known propensity of fungi
to reduce free aldehydes.[15, 16a]
Figure 1. Production of pyrichalasin H 1 in WT M. grisea NI980 and selected
mutants. UV at 275 nm.




Dihydroxylation of the skeleton of 9 at C-15/C-16 and hy-
droxylation at C-9 are consistent with modifications previously
observed in shunt metabolites (e.g. 10) in M. grisea, for exam-
ple during KO studies of the Diels–Alderase gene pyiF.[7] The
structural assignment was further confirmed by observation of
a major mass fragment at m/z 364 corresponding to a facile
homo-allylic fragmentation[22] of the polyketide triol sidechain
(Figure 3).
Heterologous expression of ACE1, RAP1 and ORFZ in
Aspergillus oryzae
Previously we had observed that when we co-expressed ACE1
+ RAP1 in A. oryzae, linear alcohol shunt products 6 a–c were
observed rather than expected aldehyde 7 (Scheme 1).[15] To
examine whether the inclusion of the corresponding a,b-hy-
drolase ORFZ prevented reduction and enabled biosynthesis of
the expected aldehyde 7 and ring-closed congeners analogous
to 4, we co-expressed ACE1, RAP1 and ORFZ in A. oryzae using
previously reported methods.[15,21] However, the same shunt in-
termediates 6 a,b were observed in the absence of exogenous
2 (Figure S6.7), while 6 c was produced in the presence of 2
(Figure S6.8). To investigate the possibility that the Diels–Alder-
ase, ORF3,[11] is also required, we co-expressed ACE1, RAP1,
ORFZ and ORF3 in A. oryzae. However, the same shunt inter-
mediates 6 a–c were again observed (Figure S6.7). PCR and RT-
PCR analyses showed that all transformed genes were being
expressed in A. oryzae, and previous complementation studies
had shown that ORFZ and ORF3 were correctly cloned. We
therefore concluded that aldehyde reduction out-competes
any ring-closing in this host. Realising that we could not inves-
tigate the function of PyiE or ORFZ in vivo, we decided to in-
vestigate the Knoevenagel reaction in vitro.
Chemical investigation of Knoevenagel step
In order to investigate the chemistry of the proposed Knoeve-
nagel step we synthesised the model compound 11 a which
features a phenylalanine-derived aldehyde similar to proposed
intermediate 3, but with a truncated b-keto polyketide de-
signed for simpler synthesis and analysis. Thus, amino-alcohol
2S-12 was treated with acetone diketene adduct 13, to give 14
and oxidised under mild Pfitzner-Moffatt conditions[23] to give
the required aldehyde 11 a. 11 a was treated with 1 m NaOH in
an attempt to generate 12 a (Scheme 2). However, in aqueous
solution 12 a rapidly equilibrates to its 1,3-dihydro tautomer
12 b. This structure is supported by: chemical shift data, espe-
cially for the C-13 methyl (dH 2.15 ppm); the chemical shift of
H-4 (dH 5.54 ppm); the chemical shifts of C-12 and C-3 (dC
Figure 2. Red trace, WT M. grisea supplemented with O-methyl tyrosine 2 ;
Green trace, M. grisea DpyiE supplemented with O-methyl tyrosine 2 ; Purple
trace, M. grisea DpyiE alone. * unrelated metabolites.
Figure 3. Structure of DpyiE shunt metabolite 9 isolated in this study and
shunt metabolite 10 isolated in the DpyiF study.[11]
Scheme 2. Synthesis of model pyrrol-2-one 12. Reagents and conditions:
(a) toluene, 100 8C; (b) EDCI, Cl2CHCO2H, DMSO:toluene 1:1, RT, 16 h; (c) 1 m
aq. NaOH, 0 8C, 5 min.




172.3 and 106.9 ppm, respectively) ; the observation of a dis-
tinct UV absorption (329 nm) corresponding to the aromatic
heterocycle; and loss of optical rotation (e.g. for 20 a [a]D =
@12.0 (c = 0.9, CH2Cl2) ; for 23, [a]D =@16.9 (c = 0.3, MeOH); for
12 [a]D = 0).
As pyrichalasin H 1 is derived from O-methyl tyrosine 2 we
also synthesised a p-methoxy derived aldehyde 20 a
(Scheme 3). L-Tyrosine 15 was protected as its N-methyl carba-
mate (MOC) and then methylated to give 16 (Scheme 3).
LiAlH4 reduction led to 17 and saponification then gave
amino-alcohol 18. Treatment with acetone diketene adduct 13
under thermolytic conditions gave 19. Modified Pfitzner–Mof-
fatt oxidation of 19 resulted in the desired compound 20 a,
which once again equilibrated with its hydrate form 20 b in
water. Aldehyde 20 a, however, was not easy to purify by flash
chromatography, although mg amounts could be purified by
reverse-phase HPLC. In an alternative route, Moffatt oxidation
of 17 earlier in the synthesis was followed by formation of the
corresponding diethyl acetal to give 21. Then basic removal of
the MOC group to 22 and attachment of the N-acetoacetyl
group using acetone diketene adduct 13 gave 23 which could
be prepared and purified at larger scale. This material could be
deprotected under mild aqueous acid conditions, followed by
neutralisation for convenient production of 20 a in situ.
Once again, brief base treatment achieved cyclisation to
give the 1,3-dihydro-2H-pyrrol-2-one tautomer 24 b. This com-
pound proved significantly less stable than the phenylalanine
analogue 12 b and it was difficult to purify and obtain full NMR
data. In aqueous solution 24 b rapidly reacted further to give a
co-eluting mixture of two new compounds 25 with m/z 263
which were more stable and which could be purified and fully
characterised. Full NMR analysis showed these compounds to
be a pair of diastereomers based on the 5-hydroxy-pyrrolid-2-
one skeleton, presumably derived by addition of water to 24 b
(Scheme 4).
In order to obtain further evidence that the obtained hetero-
cycles exist predominantly as their 1,3-dihydro-2H-pyrrol-2-one
tautomers we synthesised a model compound unable to tauto-
merise in this way. Briefly, p-methoxyaniline 26 was diazotized
at low temperature, and the resulting diazonium salt 27 was
treated with methallyl alcohol 28 in the presence of iron sul-
fate to give diazo compound 29 (Scheme 5). A Zn/HCl reduc-
tion then gave the amino alcohol 30, and the usual sequence
of acetoacetylation to 31, Moffatt oxidation to 32 and aqueous
base cyclization gave the expected 1,2-dihydro-2H-pyrrol-2-one
tautomer 33. This differed from the non-methylated com-
pound 12 b in lacking a distinct UV absorption for the pyrro-
lone (e.g. lmax shift from 329 to 275 nm); having a dH for H-4 of
7.71 rather than 5.54 ppm; different carbon chemical shifts for
C-12 and C-3 (dC 194.3 and 135.2 ppm); and a more obvious
methyl-13 ketone resonance (dH 2.51 ppm).
With synthetic aldehydes in hand we next set out to study
their behaviour under aqueous conditions, and in the presence
of preparations of the putative Knoevenagel catalyst ORFZ.
The native M. oryzae ORFZ gene was cloned into the expres-
sion vector pET28a(+), confirmed by sequencing. The plasmid
was transformed into E. coli BL21 (DE3) and ORFZ was ex-
pressed by addition of IPTG to a final concentration of 0.1-
Scheme 3. Synthesis of p-methoxy model compounds. Reagents and condi-
tions: (a) MOCCl, THF, H2O, NaHCO3 ; (b) MeI, K2CO3, DMF; (c) EDCI,
Cl2CHCO2H, DMSO:toluene 1:1, RT, 16 h; (d) (EtO)3CH, EtOH, p-TsOH, 50 8C,
16 h; (e) 25 % KOH, MeOH, H2O, 50 8C, 12 h; (f) 13, toluene 100 8C, 2 h. Scheme 4. Formation of hemiaminal diastereomers 25 ab.




1 mm (Figure S3.1). His6-ORFZ was isolated from the soluble
protein fraction using Ni-NTA chromatography and the purified
protein was analysed by ESI Q-TOF to confirm the correct se-
quence.
In vitro assays
Aldehyde 20 a was prepared at a concentration of ca 0.5 mm
in water and incubated at 28 8C. The composition of the solu-
tion was monitored by analytical LCMS. Under these conditions
20 appeared to be relatively stable as the hydrate form 20 b
(Figure 4), but cyclised slowly to form the previously character-
ised alcohols 25 ab (ca 10 % after 17 h). Aldehyde 20 was then
tested in buffer solutions. Buffers such as Tris which contain a
free amine are unsuitable for use with aldehydes so phosphate
buffer was initially tested at pH values between 6.0 and 8.0.
Under these conditions 20 behaved similarly to its reactions in
water (Figure 5). However a small amount of an additional new
compound 34 with m/z 522 was observed after 23 h. In phos-
phate at pH 7.0 a much higher proportion of alcohols 25 were
observed and the new compound with m/z 522 also increased
significantly (Figure 5).
At pH 8.0 in phosphate buffer aldehyde 20 appeared to be
quantitatively converted to the m/z 522 compound after 24 h
(Figure 6). A mass of 522 corresponds to a potential dimeriza-
tion and oxidation of 25. The experiments were therefore re-
peated under an atmosphere of N2. Under these conditions
the m/z 522 compound was no longer observed, but at pH 8.0,
for example, complete conversion to the alcohols 25 was
achieved (see Supporting Information, section S8).
New compound 34 was purified. Full NMR analysis con-
firmed this to be an oxidised dimer of the alcohol 25. A series
of intra-unit HMBC correlations (Figure 7) confirmed the pres-
ence of two different monomers, and a series of inter-unit
Scheme 5. Synthesis of a-methyl model compounds. Reagents and condi-
tions: (a) HBF4 ; (b) NaNO2, <5 8C; (c) FeSO4.7H2O; (d) Zn, HCl, MeOH, RT,
16 h; (e) 13, toluene, 100 8C, 2 h; (f) EDCI, Cl2CHCO2H, DMSO:toluene 1:1, RT,
16 h.
Figure 4. Model 20 in H2O at 28 8C over time. Alcohol 19 is a residual syn-
thetic intermediate (see Scheme 3) and not formed in the incubation.
Figure 5. Model 20 in potassium phosphate buffer (pH 7.0, 75 mm) at 28 8C
under air over time. Alcohol 19 is a residual synthetic intermediate (see
Scheme 3) and not formed in the incubation.
Figure 6. Model 20 in potassium phosphate buffer (pH 8.0, 75 mm) at 28 8C
under air over time.
Figure 7. Elucidated structure of oxidised dimer of 34.




HMBC correlations confirmed the carbon-carbon linkage
shown in Figure 7. Chemical shift considerations suggest that
carbons L and J (Figure 7) are linked via oxygen rather than
the amide nitrogen.
Further investigations into buffers indicated that HEPES
buffer induced the minimum formation of 25 and dimer 34.
Therefore this buffer was used in subsequent in vitro assays
with enzymes. Attempts were then made to observe the effect
of adding either purified ORFZ or cell-free extracts of E. coli ex-
pressing ORFZ, to 20 (e.g. Figures S8.1–S8.11). However, de-
spite numerous attempts, no catalysis could be observed.
Sequence analysis
a,b-Hydrolases related to PyiE and ORFZ are commonly found
encoded in fungal PKS-NRPS biosynthetic gene clusters, espe-
cially those with a reductive release mechanism.[17] For exam-
ple, the cytochalasin E (CcsE),[5a] fusarin (Fus2),[18a, 24] pseurotin
(PsoG),[18c] and phomacin (SnoG)[25] gene clusters all encode ho-
mologous a,b-hydrolases. No structural data for orthologs of
ORFZ/PyiE has been reported, but database (ESTHER)[26] and
structural prediction (Phyre-2,[27] Swiss-Model)[28] searches indi-
cate that well-studied enzymes such as acylaminoacyl pepti-
dase (3fnb), 2,6-dihydroxy-pseudo-oxynicotine (DHPON, 2jbw)
hydrolase,[29, 30] and AntI[31] (6hxa) possess the same overall pro-
tein fold. DHPON hydrolase catalyses a retro-aldol C@C bond
cleavage in Arthrobacter nicotinovorans (Scheme 6 A), while
AntI catalyses retro-Claisen reaction followed by a ring-closing
cyclisation during the biosynthesis of polyketide-derived an-
thraquinones in Photorhabdus luminescens (Scheme 6 B).
Sequence alignment of DHPON hydrolase, AntI, PyiE, ORFZ,
CcsE, Fus2, PsoG and SnoG was performed using COBALT,[32]
and a model structure of ORFZ was constructed in Swiss-
Model using 3fnb as a template (see Supporting Information)
to give an adequate resulting structure (QMEAN @3.48). The
ORFZ model aligns with AntI with an RMSD of 3.5 a over 344
residues and comparison of the sequence and structural align-
ments gives useful information (Figures S9.2).
AntI has a nucleophilic serine (S245) located at a ‘nucleophil-
ic elbow’ in the highly conserved motif GXSXGG.[31] This motif
and the catalytic serine is conserved in DHPON-hydrolase and
all the PyiE/ORFZ family members. In AntI S245 forms part of a
catalytic triad with D326 and essential H355. H355 has been
shown to protonate the retro-aldol nucleofuge.[31] Structural
homologs of D326 and H355 are present in DHPON-hydrolase
(D300 and H329 respectively) which also catalyses C@C bond
cleavage, but these catalytic residues are absent from PyiE,
ORFZ and the other cytochalasan hydrolases.
After the retro-Claisen reaction, AntI also catalyses a ring-
closing reaction (Scheme 6 B). This has been shown to involve
enolisation followed by a Dieckmann cyclisation. Residues
D175, S176, E181 and R24 of AntI are involved in catalysis of
this step, while Y20 is thought to be involved in substrate ori-
entation.[31] These residues are conserved in DHPON-hydrolase
and in the PyiE family of hydrolases (e.g. D174, S175, E178, R17
and F13 respectively in PyiE and D165, E169, S243, F12 and
R16 in ORFZ, Figure S9.2).
Discussion
Knock-out of pyiE in M. grisea significantly reduced the titres of
1, but initial complementation of pyiE did not restore 1 to WT
levels. When exogenous O-methyltyrosine 2 was fed to the
pyiE complemented strain, production of 1 was restored, and
new compounds were detected in the DpyiE strain (Figure 2).
This is consistent with damage to the promoter region of pyiA
which encodes the essential tyrosine O-methyl transferase. The
major new compound from the DpyiE strain chemically com-
plemented with 2 was isolated, purified and structurally char-
acterised as the linear O-methyltyrosine octaketide 9. This
compound has not undergone Knoevenagel condensation and
instead the expected aldehyde has been reduced to an alco-
hol. The shunt compound has also been oxidized at C-9, C-15
and C-16 (Figure 3) through addition of hydroxyl groups.
These modifications are highly similar to the shunt pyrichalasin
precursor 10 observed when pyiF was disrupted in M. grisea.[7]
This KO result is similar to the results of KO experiments ob-
Scheme 6. Suggested alternative ‘Hydrolase’/’Diels–Alderase’ route to the cy-
tochalasan skeleton. A, reactions catalysed by the DHPON hydrolase; B, reac-
tions catalysed by AntI ; C, suggested analogous pathway to Cytochalasans.
Note that DHPON-hydrolase may also use water directly as a nucleo-
phile.[29, 34]




served in the cases of fusarin (fus2)[18a] and pseurotin
(psoG)[18a,c] which also demonstrated that these genes are es-
sential for biosynthesis, although intermediates or precursors
were not identified.
Heterologous complementation of DpyiE strains with ORFZ
from the ACE1 BGC shows that PyiE and ORFZ have the same
function. This reinforces previous observations in which we
showed that other enzymes from the ACE1 cluster can comple-
ment the pyi pathway: for example ORF3 can complement
PyiF (the Diels–Alderase) ; and late stage tailoring enzymes
from the ACE1 pathway such as CYP1 and CYP3 are also func-
tional in the pyrichalasin system.[7]
In vitro investigations using synthetic model compounds 11
and 20 show that they do not cyclise rapidly. In water or phos-
phate buffer at pH 7.0 a very slow spontaneous Knoevenagel
cyclisation is observed, followed by further addition of water
at the b-position to give 25, and these reactions are accelerat-
ed at higher pH. In strong base the cyclisation is fast, but fur-
ther water addition does not occur. Detailed studies of the
major pyrrolinone tautomer show conclusively that the 1,3-di-
hydro-form 24 b is formed: this tautomer cannot undergo the
required Diels–Alder cyclisation. Formation of the 1,3-dihydro
tautomer 24 b also removes the a-stereocentre which is con-
served in the cytochalasans, strongly suggesting that non-en-
zymatic equilibration of 1,3- and 1,5 dihydro tautomers does
not occur during cytochalasan biosynthesis. In phosphate
buffer in the presence of atmospheric oxygen further oxidation
and dimerisation of 24 b takes place to give 34, emphasising
the inherent reactivity of these intermediates. Our attempts to
show in vitro activity of expressed and purified ORFZ with
model compound 20 were not successful. It may be that ORFZ
is incorrectly folded, as observed for many fungal protein tar-
gets of E. coli expression;[33] or that 20 is not a sufficiently elab-
orate substrate for the protein. Alternatively, ORFZ may require
interaction with other protein partners (vide infra) or the PKS-
NRPS itself. No doubt the lack of soluble and active ORFZ/PyiE
family members has limited progress in this area.
Conclusions
Taking the above observations into account we can make the
following conclusions. First, Knoevenagel reaction of putative
intermediate 3 (Scheme 1) requires catalysis by PyiE/ORFZ at
physiological pH. The model studies show the uncatalysed re-
action is slow at pH 7 and the pyiE KO studies and A. oryzae
heterologous expression studies show that intermediate alde-
hydes such as 3 are quickly reduced in vivo. This agrees with
observations from other heterologous expression studies in
our group[11, 15] and from Oikawa and co-workers,[4e, 16a] which
show that expression of early genes from cytochalasan path-
ways in A. oryzae always leads to alcohol shunt intermediates.
Corroborating observations from Lebrun and co-workers show
that ORFZ (hydrolase) and ORF3 (Diels–Alderase) are the most
highly expressed genes from the ACE1 BGC (up to 7-fold
higher than the ACE1 PKS-NRPS itself), suggesting a high con-
centration of these catalysts is required to avoid the reductive
shunt pathways.[13]
Second, the model studies show that rapid tautomerisation
of 24 a to 24 b creates a substrate which is incompetent for
further Diels–Alder reaction because the alkene is no longer
present at C-3,C-4. Tautomer 24 b is itself reactive and under-
goes other reactions leading it away from the cytochalasan
pathway. Interestingly the observed hemi-aminal functionality
of 25 ab mirrors the same functionality found in in fusarin C[18a]
and talaroconvolutin B (Figure 8),[35] for example.
These conclusions show that the previously widely held
view that Knoevenagel cyclisation leads to the formation of
the 1,5-dydro-2H-pyrrol-2-one tautomer 4 prior to Diels–Alder
catalysis is an over-simplification. We have shown that in vivo,
Knoevenagel catalysis must be rapid enough to out-compete
aldehyde shunt reduction, and that Diels–Alder reaction must
also occur very rapidly before (non-enzymatic) tautomerisation
and loss of chirality.
It is intriguing that the PyiE enzyme family preserve the nu-
cleophilic active site serine at a ‘nucleophilic elbow’ position
found in DHPON hydrolase and AntI, but lack the acid/base
residues required for retro-Claisen reaction. However the acid/
base residues shown by Bode and co-workers to be involved
in cyclisation in AntI are conserved in PyiE and ORFZ.[31] This
suggests that an alternative possible mechanism for PyiE and
its homologues could involve addition of the serine nucleo-
phile of PyiE/ORFZ to the b-ketone of 20 during reaction
(Scheme 6 C) to give an enzyme-bound tetrahedral intermedi-
ate, without retro Claisen cleavage because of the lack of the
catalytic triad H and D residues. The formation of a tetrahedral
centre at the b-position would prevent incorrect tautomerisa-
tion, providing the correct (enzyme-bound) substrate for the
subsequent Diels–Alder reaction. This in-turn suggests that the
hydrolase (e.g. PyiE/ORFZ) and Diels–Alderase (e.g. PyiF/ORF3)
catalysts may work closely together or as a hetero-dimer, or
conceivably with the PKS-NRPS itself. However, further detailed
in vitro experiments will be required to test this idea, and
more reliable methods for the production of soluble and active
PyiE/ORFZ and PyiF/ORF3 proteins will be required to probe
this hypothesis further. However synthetic and analytic prog-
ress made here sets the scene for future advances in this area.
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